Skip to content
GrantCompassUS See your grants
between-intakes State Grant

MassVentures START Grant Program

MassVentures (Massachusetts Technology Development Corporation)

$100K / $200K / up to $500K

Researched for this program: 4 rejection traps · 1 required documentWhat decides this award ↓

The short version

Phase II SBIR holder? MassVentures bridges to market

MassVentures START provides tiered non-dilutive grants — $100K (Round 1), $200K (Round 2), or up to $500K in seed capital (Round 3) — to Massachusetts companies that have received a federal SBIR Phase II award. Funds commercialization activities not typically covered by federal R&D grants: market validation, business development, and IP strategy. Applications open annually in February; each round builds on the prior.

Funding type
Grant
Level
State
Amount range
$100,000 – $500,000
Realistic amount
Most applicants are awarded Round 1 ($100,000). Approximately 7 companies advance to Round 2 ($200K) and 3 to Round 3 ($500K) per annual cohort.
Deadline
Application window opens February 1 annually; 2026 Round 1 deadline was February 23. Next open window: February 1, 2027.
Status
between-intakes
States
MA
Payment model
advance

Who qualifies

Hard requirements

What it covers

Eligible expenses

  • Market validation studies and customer discovery research
  • Business development and partnership outreach
  • Intellectual property strategy and patent filings
  • Hiring of commercialization-focused staff (sales, BD, marketing)
  • Go-to-market planning and execution activities

Ineligible expenses

  • R&D expenditures already allowable under the federal SBIR Phase II award
  • Capital equipment purchases unrelated to commercialization
  • Real estate acquisition or leasehold improvements
  • Activities that duplicate the federal Phase II scope of work

How to apply

  1. 1

    Confirm SBIR Phase II eligibility

    Verify your company holds a qualifying federal SBIR Phase II award issued within the past 5 years from any participating federal agency (NIH, DOE, NSF, DOD, NASA, etc.).

  2. 2

    Prepare commercialization plan

    Document your commercialization roadmap — market validation steps, business development goals, IP protection plan, and how START funds will accelerate go-to-market. MassVentures reviewers evaluate commercial credibility, not additional R&D.

  3. 3

    Submit online application during the February window

    Apply via the MassVentures online portal during the annual February application period. Applications are typically open for approximately 3 weeks.

  4. 4

    Round 1 review and award ($100K)

    Reviewers assess commercial strategy and Massachusetts economic impact. Approximately 16 companies per cohort receive $100K Round 1 awards.

  5. 5

    Progress review for Rounds 2 and 3

    Top Round 1 performers (approx. 7) are invited to compete for $200K Round 2 awards. Top Round 2 companies (approx. 3) compete for up to $500K Round 3 seed capital.

Insider tip

Only Phase II holders qualify — not Phase I. Competition is selective: ~16 Round 1 awards per year from a MA deep-tech pool.

Deadline & timing

2026 Round 1 applications closed February 23, 2026. The next annual application window will open February 1, 2027. No interim rounds.

Not accepting applications right now — get one email when it reopens

GrantCompass tracks MassVentures START Grant Program’s application windows in the live catalog. Leave an email and we’ll tell you the day the next window opens.

Free. One email when the window moves, deadline warnings on your watchlist, and the monthly closing-soon digest. Unsubscribe anytime.

Programs that stack well

Related programs

This program is not taking applications today — these are

Alternatives computed from the live GrantCompass catalog on November 1, 2026 — all 170 open grant programs · filter the database.

Explore more funding

Last updated October 22, 2026. GrantCompass is an independent funding-discovery tool and is not affiliated with any government agency. Always confirm details on the official program page.